Anxiety DisordersDepressive DisordersSubstance Use Disorders (SUD)Safety & Risk ManagementIbogaine

An analog of psychedelics restores functional neural circuits disrupted by unpredictable stress

In mice subjected to unpredictable mild stress, a single dose of the psychedelic analogue tabernanthalog (TBG) reduced anxiety and rescued deficits in sensory processing and cognitive flexibility. TBG achieved this by promoting regrowth of excitatory dendritic spines, lowering baseline neuronal activity and restoring stimulus‑dependent responses in somatosensory cortical circuits.

Authors

  • David Olson
  • Lindsay Cameron
  • Bing Cao

Published

Molecular Psychiatry
individual Study

Abstract

Psychological stress affects a wide spectrum of brain functions and poses risks for many mental disorders. However, effective therapeutics to alleviate or revert its deleterious effects are lacking. A recently synthesized psychedelic analog tabernanthalog (TBG) has demonstrated anti-addictive and antidepressant potential. Whether TBG can rescue stress-induced affective, sensory, and cognitive deficits, and how it may achieve such effects by modulating neural circuits, remain unknown. Here we show that in mice exposed to unpredictable mild stress (UMS), administration of a single dose of TBG decreases their anxiety level and rescues deficits in sensory processing as well as in cognitive flexibility. Post-stress TBG treatment promotes the regrowth of excitatory neuron dendritic spines lost during UMS, decreases the baseline neuronal activity, and enhances whisking-modulation of neuronal activity in the somatosensory cortex. Moreover, calcium imaging in head-fixed mice performing a whisker-dependent texture discrimination task shows that novel textures elicit responses from a greater proportion of neurons in the somatosensory cortex than do familiar textures. Such differential response is diminished by UMS and is restored by TBG. Together, our study reveals the effects of UMS on cortical neuronal circuit activity patterns and demonstrate that TBG combats the detrimental effects of stress by modulating basal and stimulus-dependent neural activity in cortical networks.

Available with Blossom Pro

Research Summary of 'An analog of psychedelics restores functional neural circuits disrupted by unpredictable stress'

Introduction

Stress caused by unpredictable adverse events can produce widespread synaptic, circuit, and behavioural disturbances and is implicated in many psychiatric disorders. Previous rodent work has shown region-specific dendritic atrophy and spine loss (for example in hippocampus, medial prefrontal and somatosensory cortices), disruption of excitation–inhibition balance, and resultant impairments in anxiety regulation, sensory processing, and cognitive flexibility. Although classical psychedelics (LSD, psilocybin, DMT and related compounds) have returned to clinical research because of promising efficacy in depression, anxiety and addiction, their hallucinogenic properties limit therapeutic use. Tabernanthalog (TBG), a synthetic analogue of 5-MeO-DMT, was reported to have antidepressant and anti-addictive potential without producing the mouse head-twitch response, but its ability to reverse stress-induced structural and functional brain changes was not known. Lu and colleagues set out to test whether a single post-stress dose of TBG could reverse behavioural deficits produced by an unpredictable mild stress (UMS) protocol in mice, and to determine the underlying neural circuit mechanisms. Specifically, the study examined anxiety-like behaviour, sensory discrimination and cognitive flexibility, dendritic spine dynamics on cortical pyramidal neurons, mesoscopic and cellular calcium activity in barrel cortex during whisking and texture discrimination, and intrinsic excitability of parvalbumin-expressing inhibitory interneurons (PV+ INs). The goal was to link behavioural rescue with synaptic and network-level changes induced by TBG in the stressed brain.

Expert Research Summaries

Go Pro to access AI-powered section-by-section summaries, editorial takes, and the full research toolkit.

Study Details

References (11)

Papers cited by this study that are also in Blossom

The History of Psychedelics in Psychiatry

Nichols, D. E., Walter, H. · Pharmacopsychiatry (2020)

Antidepressant effects of a single dose of ayahuasca in patients with recurrent depression a SPECT study

Sanches, R. F., Osório, F. L., Dos Santos, R. G. et al. · Journal of Clinical Psychopharmacology (2016)

380 cited
Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study

Carhart-Harris, R. L., Bolstridge, M., Rucker, J. et al. · Lancet Psychiatry (2016)

1174 cited
Pilot study of the 5-HT2AR agonist psilocybin in the treatment of tobacco addiction

Johnson, M. W., Garcia-Romeu, A., Cosimano, M. P. et al. · Journal of Psychopharmacology (2014)

Psilocybin-assisted treatment for alcohol dependence: a proof-of-concept study

Bogenschutz, M. P., Forcehimes, A. A., Pommy, J. A. et al. · Journal of Psychopharmacology (2015)

A non-hallucinogenic psychedelic analogue with therapeutic potential

Cameron, L. P., Tombari, R. J., Lu, J. et al. · Nature (2020)

70 cited
Psychedelics promote structural and functional neural plasticity

Ly, C., Greb, A. C., Cameron, L. P. et al. · Cell Reports (2018)

Hallucinogens and Serotonin 5-HT2A Receptor-Mediated Signaling Pathways

López-Giménez, J. F., González-Maeso, J. · Current Topics in Behavioral Neurosciences (2017)

211 cited
The therapeutic potential of psychedelic drugs: past, present, and future

Carhart-Harris, R. L., Goodwin, G. M. · Neuropsychopharmacology (2017)

Show all 11 references

Cited By (13)

Papers in Blossom that reference this study

1 cited
The psychoplastogen tabernanthalog induces neuroplasticity without proximate immediate early gene activation

Aarrestad, I. K., Cameron, L. P., Fenton, E. M. et al. · Nature Neuroscience (2025)

Psilocybin’s lasting action requires pyramidal cell types and 5-HT2A receptors

Shao, L-X,, Tan, D., Liao, C., Davoudian, P. A. et al. · Nature Communications (2025)

Structural neural plasticity evoked by rapid-acting antidepressant interventions

Liao, C., Dua, A. N., Wojtasiewicz, C. et al. · Nature Reviews Neuroscience (2024)

Main targets of ibogaine and noribogaine associated with its putative anti-addictive effects: A mechanistic overview

Ona, G., Reverte, I., Rossi, G. N. et al. · Journal of Psychopharmacology (2023)

Therapeutic mechanisms of psychedelics and entactogens

Heifets, B. D., Olson, D. E. · Neuropsychopharmacology (2023)

Canalization and plasticity in psychopathology

Carhart-Harris, R. L., Chandaria, S., Erritzoe, D. E. et al. · Neuropharmacology (2023)

Neural Mechanisms and Psychology of Psychedelic Ego Dissolution

Stoliker, D., Egan, G. F., Friston, K. J. et al. · Pharmacological Reviews (2022)

Show all 13 papers
Psychedelic Therapy's Transdiagnostic Effects: A Research Domain Criteria (RDoC) Perspective

Dursun, S. M., Kelly, J. R., Gillan, C. M. et al. · Frontiers in Psychiatry (2021)

Psychedelic-Inspired Approaches for Treating Neurodegenerative Disorders

Olson, D. E. · Journal of Neurochemistry (2021)

Serotonergic Psychedelics in Neural Plasticity

Torregrossa, M. M., Lu, J., Lukasiewicz, K. et al. · Frontiers in Molecular Neuroscience (2021)

Your Personal Research Library

Go Pro to save papers, add notes, rate studies, and organize your research into custom shelves.